Definitive Contract 75F40126C00054
Award Date 9/1/26
Potential Completion Date 8/31/28
Potential Value $1.5M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55414, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $4,999,953.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the National Institute for Pharmaceutical Technology & Education Inc. (Nipte), a non-profit organization. The contract was awarded under the FDA's Broad Agency Announcement mechanism to support research and development on a "model-based systems engineering approach to end-to-end pharmaceutical manufacturing of liquid" products. This contract is not associated with a...
- The Food and Drug Administration awarded a $499,000 firm fixed-price purchase order to the National Institute For Pharmaceutical Technology & Education Inc. (Nipte) on September 13, 2013, for a Generic Drug User Fee Act (GDUFA) study evaluating drug product formulation. The contract, which was completed by September 15, 2015, was performed in Rosemont, Illinois. No set-aside designation was applied to this award. Nipte, a non-profit collaboration of academic, industry, and other...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $743,717.94 Definitive Contract to the National Institute For Pharmaceutical Technology & Education Inc. (Nipte), a non-profit organization, to conduct research and development on the assessment of smoking and vaping risk of opioids and commercial products, as well as the standardization of methods to assess these properties. This contract was issued under the FDA's Broad Agency Announcement...
- The U.S. Food and Drug Administration (FDA) awarded a $901,888.19 definitive contract to the National Academy of Sciences (NAS), a non-profit organization, to produce a consensus report that identifies innovative technologies to advance pharmaceutical manufacturing. The contract, which is not set aside, was awarded on July 19, 2019 with a completion date of March 31, 2022. The report will assist the FDA's Center for Drug Evaluation and Research (CDER) in fostering the adoption of innovative...
- <p>The Food and Drug Administration issued a purchase order to the National Academy of Sciences on September 18, 2024, valued at $100,000.00, for FDA support to the NASEM Leadership Consortium. The order is firm fixed price with no set-aside designation. Performance takes place in Washington, DC 20418. Ultimate completion is scheduled for September 29, 2025.</p>
- This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...
- <p>The National Institute on Drug Abuse issued a delivery order to Foundation For Advanced Education In The Sciences, Inc. on August 1, 2023, with a ceiling value of $118,020.41 for administration of the Masters of Professional Studies Fellowship Program.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of May 7, 2026. No set-aside was used.</p>
- The Food and Drug Administration awarded a $6.04M firm fixed-price definitive contract to Massachusetts Institute of Technology on September 18, 2024, with completion expected by June 28, 2026. This award supports the development of a Broad Agency Announcement addressing continuous manufacturing growth within cell lines, funded through the President's initiative focused on advanced manufacturing. The work will be performed in Cambridge, Massachusetts, and no set-aside designation was applied...
- This federal contract award was made by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to The United States Pharmacopeial Convention, Inc. (USP), an independent, non-profit organization that sets standards for medicines, food ingredients, and dietary supplements. The $97,265.00 firm fixed-price purchase order contract is for USP to provide web-based platforms and online access to the United States Pharmacopeia National...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>